Il Chip Multi-organo - Una piattaforma Microfluidic per lungo termine co-coltura Multi-tessuto
28 aprile 2015
32.3K visualizzazioni
Qui, presentiamo un protocollo per la co-coltura di cellule primarie, modelli di tessuto e biopsie a punzone in un chip multiorgano microfluidico per un massimo di 28 giorni. Le cellule endoteliali microvascolari dermiche umane, gli aggregati epatici e le biopsie cutanee sono stati combinati con successo in una comune circolazione dei media.
Panoramica
Questo articolo presenta un protocollo per la cocoltura di cellule primarie, modelli di tessuto e biopsie punch utilizzando un chip multi-organo microfluidico per un massimo di 28 giorni. È dettagliata la combinazione di successo di cellule endoteliali microvascolari derma umano, aggregati epatici e biopsie cutanee in una circolazione media comune.
Componenti Chiave dello Studio
Area della Scienza
- Neuroscienze
- Biologia Cellulare
- Microfluidica
Contesto
- I sistemi microfluidici consentono l'integrazione di molteplici sistemi di organi.
- Le tecniche di cocoltura possono migliorare lo studio delle interazioni cellulari.
- Mantenere la vitalità e la funzionalità delle cellule per periodi prolungati è cruciale.
- Questo studio esplora il potenziale di un chip multi-organo per la coltura a lungo termine.
Obiettivo dello Studio
- Sviluppare un protocollo affidabile per la cocoltura di diversi tipi di cellule.
- Indagare le interazioni tra cellule endoteliali e modelli di tessuto.
- Valutare la vitalità delle cellule in un ambiente microfluidico nel tempo.
Metodi Utilizzati
- Progettazione e fabbricazione del chip microfluidico.
- Isolamento di cellule endoteliali microvascolari derma umano primarie.
- Preparazione di aggregati epatici e biopsie cutanee.
- Stabilimento di una circolazione media comune per la cocoltura.
Risultati Principali
- Cocoltura di successo di cellule endoteliali, aggregati epatici e biopsie cutanee.
- Le cellule hanno mantenuto la vitalità fino a 28 giorni.
- Osservazioni delle interazioni cellulari nell'ambiente microfluidico.
- Potenziali applicazioni nei test farmacologici e nella modellazione delle malattie.
Conclusioni
- Il chip multi-organo microfluidico è efficace per la cocoltura a lungo termine.
- Questo approccio può facilitare lo studio di interazioni cellulari complesse.
- La ricerca futura può espandere le applicazioni di questa tecnologia.
Domande Frequenti
Che cos'è un chip multi-organo microfluidico?
Un chip multi-organo microfluidico è un dispositivo che consente la coltura simultanea di molteplici tipi di cellule in un ambiente controllato.
Per quanto tempo le cellule possono essere coltivate in questo sistema?
Le cellule possono essere coltivate fino a 28 giorni nel chip multi-organo microfluidico.
Che tipi di cellule sono stati utilizzati in questo studio?
Nello studio sono state utilizzate cellule endoteliali microvascolari derma umano, aggregati epatici e biopsie cutanee.
Quali sono le potenziali applicazioni di questa ricerca?
Le potenziali applicazioni includono i test farmacologici e la modellazione delle malattie in un ambiente controllato.
Quali sono i vantaggi dell'utilizzo di tecniche di cocoltura?
Le tecniche di cocoltura possono migliorare la comprensione delle interazioni cellulari e migliorare la rilevanza dei modelli in vitro.
Come funziona la circolazione dei media nel chip?
La circolazione dei media consente lo scambio di nutrienti e prodotti di scarto, supportando la vitalità e la funzione delle cellule.
Executive Industry Relevance
Long-term multi-tissue coculture in a microfluidic platform addresses the critical need for predictive preclinical models that better capture organ-organ interactions and chronic substance exposure effects. By enabling stable, near-physiologic fluid flow and repeated dosing over 28 days, the system supports mechanistic de-risking in early discovery and improves translational confidence for hepatotoxicity and dermal safety assessment. This positions the technology as a reusable capability for lead identification and predictive modeling in pharmaceutical R&D pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of cross-tissue signaling pathways and mechanistic de-risking of compound-induced organ interactions.
- Operational Value: Supports functional validation of targets in a multicellular microenvironment that reflects physiological complexity.
Screening & Assay Development
- Scientific Value: Provides a standardized, reproducible platform for quantitative assessment of substance effects across interconnected tissue models.
- Operational Value: Enables scalable, long-term coculture with media perfusion for repeated compound exposure and readout collection.
Translational & Preclinical Research
- Scientific Value: Enhances disease relevance by modeling human liver-skin-vascular interactions in a controlled, perfused system.
- Operational Value: Supports continuity from discovery through preclinical evaluation by maintaining tissue functionality over extended culture periods.
Pipeline & Workflow Integration
The microfluidic multi-organ chip integrates into early discovery workflows by enabling hypothesis testing of organ-specific toxicities and pathway modulation in a human-relevant coculture system.
- Discovery Biology: Facilitates hypothesis testing of inter-organ communication and compound effects on tissue-specific functions.
- Screening: Delivers assay readiness through stable, perfused coculture conditions suitable for compound library screening.
- Analytics: Generates quantitative, time-resolved readouts from multiple tissue compartments to support comparative condition analysis.
- Translational Research: Promotes preclinical continuity by preserving organotypic architecture and function over 28-day culture periods.
- Enterprise Reuse: Offers a reusable perfusion platform adaptable to multiple tissue combinations and compound testing campaigns.
Operational & Enterprise Impact
- Scientific Value: Improves predictive confidence by reducing mechanistic ambiguity in organ-organ crosstalk and substance response.
- Operational Value: Ensures standardization, reproducibility, and scalability of long-term multicellular coculture under controlled flow.
- Strategic Value: Informs better go/no-go decisions by identifying organ-specific liabilities earlier, reducing late-stage attrition risk.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on multi-tissue tolerance and functional readouts.
Implementation Considerations
- Requires expertise in microfluidic system operation, primary cell handling, and tissue model preparation.
- Depends on perfusion-compatible instrumentation, sterile fluid handling, and real-time monitoring infrastructure.
- Necessitates cross-team standardization of media formulations, flow rates, and sampling protocols for reproducible results.
- Involves adaptation considerations when integrating diverse primary tissues or biopsies with varying culture requirements.
- Limited by the need for specialized fabrication and validation of chip designs to maintain physiologic shear stress and volume ratios.
Biopharma FAQs
Why is long-term culture important for target validation studies?
Long-term culture enables repeated substance exposure and observation of delayed or cumulative toxic effects, which are critical for validating targets in chronic disease models. The system supports coculture viability for up to 28 days, allowing assessment of sustained target engagement and organ-specific responses over time. This duration improves predictive confidence by mimicking human dosing regimens and revealing late-onset organ interactions not captured in short-term assays.
How does independent variable isolation improve discovery pipeline efficiency?
The microfluidic design allows precise control of fluid flow, media composition, and tissue positioning, enabling isolation of variables such as shear stress or compound concentration. This control reduces confounding factors in coculture experiments, improving data reliability for target validation and lead optimization. By standardizing these parameters, teams can compare conditions across experiments with greater reproducibility and fewer false positives.
What quantitative measurements does the system enable for dependent variables?
The platform supports quantitative readouts such as metabolite secretion, enzyme activity, barrier integrity, and viability markers from each tissue compartment. These measurements allow dose-response modeling and kinetic analysis of substance effects across interconnected tissues. Time-resolved sampling via the perfusion system enables longitudinal tracking of functional changes, supporting mechanistic insight and safety margin estimation.
Why are replication requirements essential for cross-functional collaboration?
Replication ensures that observed tissue responses are consistent and not due to stochastic variability in cell seeding or chip preparation. Standardized protocols for liver aggregate formation, skin biopsy placement, and endothelial seeding allow toxicology, DMPK, and biology teams to generate comparable data. This consistency supports joint interpretation of results and alignment on go/no-go criteria in multidisciplinary project teams.
What statistical analysis capabilities are needed before implementing this system?
Implementation requires the ability to perform longitudinal data analysis, including repeated measures ANOVA or mixed-effects models, to account for temporal correlations in perfusion-based readouts. Teams must also apply correction for multiple comparisons when assessing multiple tissue endpoints or time points. These capabilities ensure that observed differences are statistically robust and not driven by noise, supporting confident decision-making in preclinical evaluation.
